InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Discover the complete record of transactions filed by Rosett Max. Director active across 1 company, notably Immunome Inc.. In total, 6 disclosures have been logged. Split: 0 buy · 2 sells. Total volume traded: €1.2m. Activity tracked since 19 September 2024. The latest transaction was disclosed on 23 July 2026 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 条申报中的 6 条
Rosett Max is a declarant linked to Immunome Inc. (XNAS), where the listed role is Chief Financial Officer. He has filed 5 forms in total, and across the 5 sampled filings, sales total 1234576 EUR between 2024-09-20 and 2026-04-03, with Levée d'options as the most common transaction nature.